Skip to content
Clinical Trials – home
FinlandBack to Finland

Clinical trials in Oulu

183 clinical trials in Oulu, Finland across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Oulu at a glance
183
clinical trials
  • Research sites5
Type of trial
Recruitment status
Quick filters

183 trials in Oulu

Open in trial search
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:DROSPIRENONE
  • Sponsor:Chemo Research S.L.
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Iti-1284
  • Sponsor:Intra-Cellular Therapies Inc.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Institut Gustave Roussy
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Genmab A/S
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Oulu

What the registry says about research in the country

01 Infectious Disease Prevention

Innovative clinical trials focusing on vaccine development against various infectious diseases, including studies of RSV, influenza, and meningococcal vaccines for different age groups.

  • Respiratory Syncytial Virus (RSV) Prevention
  • Influenza Vaccine Development
  • Meningococcal Disease Protection

Multiple studies evaluating immune responses and safety profiles in both pediatric and elderly populations.

02 Cancer Research

Advanced trials in oncology, with particular focus on prostate cancer and lymphoma treatments, including innovative approaches to central nervous system malignancies.

  • Metastatic Prostate Cancer
  • Primary CNS Lymphoma
  • Follicular Lymphoma

Studies combining chemotherapy with novel therapeutic approaches for improved patient outcomes.

03 Surgical and Emergency Medicine

Research examining surgical interventions and emergency treatments, including studies on appendicitis management and advanced imaging techniques for acute conditions.

  • Acute Appendicitis Treatment
  • Frostbite Therapy
  • Gastric Cancer Surgery

Comparative studies of surgical versus non-surgical approaches in acute medical conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).